Full CoverageTop news
Pfizer Study of Covid-19 Vaccine in Pregnant Women Delayed by Slow Enrollment
By Jared S. Hopkins & Sarah Toy
A CDC Panel Backs Booster Shots For Older Adults, A Step Toward Making Them Available
By Emma Bowman
Covid vaccines are on the way for younger children. Here's why they're different
By Amanda Sealy & Maggie Fox
All coverage
EXCLUSIVE EU regulator to decide on Pfizer booster dose at the start of October
By Emilio Parodi & Francesco Guarascio
Vaccine protection against Covid-19 wanes over time, especially for older people, CDC says
By Maggie Fox & Jamie Gumbrecht
Medical exemptions for the COVID-19 vaccine: Severe allergic reactions qualify, but little else
By Megan Cerullo
Advisory committee recommends wide swath of Americans be offered Covid-19 vaccine boosters
By Helen Branswell
Pressure Grows on U.S. Companies to Share Covid Vaccine Technology (Published 2021)
By Sheryl Gay Stolberg & Stephanie Nolen
FDA authorizes booster dose of Pfizer COVID-19 vaccine for people 65 and older, high-risk workers
By Elizabeth Weise & Karen Weintraub
What COVID Booster Shots Can and Can't Do
By Helen Rosner
Moderna vs. Pfizer: Both Knockouts, but One Seems to Have the Edge (Published 2021)
By Apoorva Mandavilli
Coronavirus updates: Covid News: Delta Variant Is Overwhelming Alaska, Site of Worst U.S. Outbreak (Published 2021)
By Apoorva Mandavilli, Dan Levin & Mike Baker
F.D.A. Authorizes Pfizer Booster Shot for Higher-Risk People
By Sharon LaFraniere & Noah Mercer Weiland